Nalaganje...
CDK4 inhibition diminishes p53 activation by MDM2 antagonists
The genes encoding MDM2 and CDK4 are frequently co-amplified in sarcomas, and inhibitors to both targets are approved or clinically tested for therapy. However, we show that inhibitors of MDM2 and CDK4 antagonize each other in their cytotoxicity towards sarcoma cells. CDK4 inhibition attenuates the...
Shranjeno v:
| izdano v: | Cell Death Dis |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Nature Publishing Group UK
2018
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6133967/ https://ncbi.nlm.nih.gov/pubmed/30206211 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41419-018-0968-0 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|